Phathom Pharmaceuticals Inc (PHAT)
9.34
-0.11
(-1.16%)
USD |
NASDAQ |
Nov 22, 16:00
9.32
-0.02
(-0.21%)
Pre-Market: 20:00
Phathom Pharmaceuticals Debt to Equity Ratio: -0.9392 for Sept. 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2024 | -0.9392 |
| June 30, 2024 | -0.7459 |
| Date | Value |
|---|---|
| March 31, 2024 | -1.004 |
| December 31, 2023 | -1.894 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-1.894
Minimum
Dec 2023
-0.7459
Maximum
Jun 2024
-1.146
Average
-0.9714
Median
Debt to Equity Ratio Benchmarks
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 387.04M |
| Total Liabilities (Quarterly) | 574.16M |
| Shareholders Equity (Quarterly) | -187.11M |
| Current Ratio | 5.726 |
| Net Debt Paydown Yield | -0.44% |